These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 28398384)
1. [OAC and NOAC... and why not also VOAC? Considerations on the terminology and acronyms of oral anticoagulants]. Rubboli A; Cuccia C; Fresco C G Ital Cardiol (Rome); 2017 Mar; 18(3):251. PubMed ID: 28398384 [No Abstract] [Full Text] [Related]
2. Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology. Lip GYH; Camm AJ; Hylek EM; Halperin JL; Weitz JI Chest; 2014 May; 145(5):1177-1178. PubMed ID: 24798856 [No Abstract] [Full Text] [Related]
4. [Non-vitamin K oral anticoagulants and cardioversion]. Amara W Ann Cardiol Angeiol (Paris); 2015 Nov; 64(5):368-71. PubMed ID: 26482623 [TBL] [Abstract][Full Text] [Related]
5. Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation. Hellfritzsch M; Husted SE; Grove EL; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):187-194. PubMed ID: 27580086 [TBL] [Abstract][Full Text] [Related]
6. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study. Martinez C; Katholing A; Wallenhorst C; Freedman SB Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112 [TBL] [Abstract][Full Text] [Related]
7. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study. Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V; J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096 [TBL] [Abstract][Full Text] [Related]
8. Nonvitamin K antagonist oral anticoagulants in everyday practice: Stroke prevention in atrial fibrillation and treatment of venous thromboembolism. Bentz BA J Am Assoc Nurse Pract; 2015 Dec; 27(12):721-31. PubMed ID: 26676209 [TBL] [Abstract][Full Text] [Related]
9. New oral anticoagulants for the prevention of thromboembolic complications in atrial fibrillation: a single centre experience. Gorczyca-Michta I; Wożakowska-Kapłon B Kardiol Pol; 2015; 73(2):85-93. PubMed ID: 25179482 [TBL] [Abstract][Full Text] [Related]
10. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial. De Caterina R; John Camm A Europace; 2016 Jan; 18(1):6-11. PubMed ID: 26450845 [TBL] [Abstract][Full Text] [Related]
11. [Bleedings under NOAC (non Vitamin-K dependent oral anticoagulants). Evidence and practical management]. Koscielny J; Rutkauskaite E Hamostaseologie; 2015; 35 Suppl 1():S43-53. PubMed ID: 26540130 [TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice. Wrigley BJ; Lip GY; Shantsila E Int J Clin Pract; 2010 Jun; 64(7):835-8. PubMed ID: 20584215 [No Abstract] [Full Text] [Related]
13. [New oral anticoagulants: from theory to practice]. de Moerloose P; Casini A; Boehlen F; Fontana P Rev Med Suisse; 2013 Jan; 9(369):104-7. PubMed ID: 23409645 [TBL] [Abstract][Full Text] [Related]
14. Extended non-vitamin K antagonist oral anticoagulation therapy for prevention of recurrent venous thromboembolism. Piovella F; Iosub DI Thromb Res; 2017 Apr; 152():87-92. PubMed ID: 28017344 [TBL] [Abstract][Full Text] [Related]
15. Non-vitamin K antagonist oral anticoagulants and heart failure. Isnard R; Bauer F; Cohen-Solal A; Damy T; Donal E; Galinier M; Hagège A; Jourdain P; Leclercq C; Sabatier R; Trochu JN; Cohen A Arch Cardiovasc Dis; 2016 Nov; 109(11):641-650. PubMed ID: 27836786 [TBL] [Abstract][Full Text] [Related]
16. Are New Oral Anticoagulants Safer Than Vitamin K Antagonists in the Treatment of Venous Thromboembolism? Kolinsky DC; Schwarz ES Ann Emerg Med; 2016 Apr; 67(4):455-7. PubMed ID: 26440492 [No Abstract] [Full Text] [Related]
17. New oral anticoagulants versus vitamin K antagonists in countries with good INR control. Coppens M Neth J Med; 2013 May; 71(4):168-9. PubMed ID: 23723109 [No Abstract] [Full Text] [Related]
18. Update on perioperative bridging in patients on chronic oral anticoagulation. Faltas B; Kouides PA Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1533-9. PubMed ID: 19954315 [TBL] [Abstract][Full Text] [Related]
19. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview. Rubboli A; Faxon DP; Juhani Airaksinen KE; Schlitt A; Marín F; Bhatt DL; Lip GY Thromb Haemost; 2014 Dec; 112(6):1080-7. PubMed ID: 25298351 [TBL] [Abstract][Full Text] [Related]
20. Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants. Turagam MK; Velagapudi P; Flaker GC Clin Interv Aging; 2015; 10():1431-44. PubMed ID: 26366064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]